Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Merck's Q3 earnings beat estimates, but company lowers guidance
07:07am, Thursday, 31'st Oct 2024
Merck's stock swung between gains and losses in premarket action.
Merck third quarter better than expected, but Gardasil sales sag in China again
06:35am, Thursday, 31'st Oct 2024
Merck & Co posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment Keytruda, but the U.S. drugmaker also flagged a second straight quarter of
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
06:33am, Thursday, 31'st Oct 2024
Merck reported third-quarter revenue and adjusted earnings that topped expectations. The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal
Merck Announces Third-Quarter 2024 Financial Results
06:30am, Thursday, 31'st Oct 2024
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Third-Quarter 2024 Financial Results.
3 Dividend Stocks That Could Raise Their Payouts in November
06:30am, Thursday, 31'st Oct 2024
These dividend stocks can be excellent options for buy-and-hold investors.
Merck's Earnings Need to Reassure Investors That All Is Well
05:07pm, Wednesday, 30'th Oct 2024
The drug company had a disastrous second quarter. It doesn't want a repeat performance.
Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?
01:10pm, Monday, 28'th Oct 2024
Let's look at five pharma and drug companies, PFE, LLY, ABBV, MRK and BMY, that are scheduled to release their third-quarter 2024 results this week.
Exploring Analyst Estimates for Merck (MRK) Q3 Earnings, Beyond Revenue and EPS
10:21am, Monday, 28'th Oct 2024
Get a deeper insight into the potential performance of Merck (MRK) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for som
RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (Nasdaq: MRNA), today announced the initiatio
Where Will Merck Be in 5 Years?
05:11pm, Friday, 25'th Oct 2024
There's a lot to like here.
BetterInvesting™ Magazine Update on Merck (MRK) and Ball (BALL)
04:15pm, Friday, 25'th Oct 2024
TROY, Mich. , Oct. 25, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Merck & Co. (NYSE: MRK) as its "Stock to Study" and Ball
3-Stock Lunch: Merck, Ecolab & Xylem Inc
03:28pm, Friday, 25'th Oct 2024
Anthony Forcione, Rockland Trust vice president, joins 'Power Lunch' to discuss stock plays for three stocks.
Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat
02:56pm, Friday, 25'th Oct 2024
Merck & Co., Inc.'s Q3 earnings report is anticipated on 31st October — next Thursday. Despite strong Q2 performance, Merck's stock fell due to a guidance downgrade related to issues with key drugs
Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?
01:46pm, Friday, 25'th Oct 2024
Investor focus is likely to be on the sales of Merck's blockbuster oncology medicine, Keytruda, when the company reports third-quarter earnings.
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for
11:06am, Thursday, 24'th Oct 2024
Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
